CLINICAL TRIALS PROFILE FOR RYZOLT
✉ Email this page to a colleague
All Clinical Trials for RYZOLT
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04752384 ↗ | Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients | Recruiting | Medical College of Wisconsin | Phase 2 | 2021-07-08 | This is a single-arm prospective clinical trial to determine the safety and feasibility of using transdermal buprenorphine in alleviation of radiation induced mucositis pain in head and neck cancer patients. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for RYZOLT
Condition Name
Clinical Trial Locations for RYZOLT
Trials by Country
Clinical Trial Progress for RYZOLT
Clinical Trial Phase
Clinical Trial Sponsors for RYZOLT
Sponsor Name